VASCULAR BIOSCIENCES has a total of 21 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHENG JIN Q, ATOSSA GENETICS INC and LA JOLLA PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Foods and drinks | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Computational chemistry | |
#8 | Enzymes | |
#9 | Bioinformatics | |
#10 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Mann David | 14 |
#2 | Komatsu Masanobu | 7 |
#3 | Ruoslahti Erkki | 7 |
#4 | Mann David M | 4 |
#5 | Mann David Marshall | 3 |
Publication | Filing date | Title |
---|---|---|
US2014323335A1 | Methods of novel therapeutic candidate identification through gene expression analysis in vascular related diseases | |
US2016022759A1 | Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis | |
US2015133458A1 | Orally active, cell-penetrating homing peptide and methods of using same |